OGS (OGS)

$5.4B
Market Cap
19.5
P/E Ratio
0.76
Beta
3.20%
Dividend Yield
Piotroski 6/9Altman Z 1.1 DistressBeneish M -2.53 CleanROIC−WACC -2.8%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 6/9, Altman Z 1.1.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The underlying economics of OGS present a mixed fundamental profile characterized by robust profitability metrics that are not yet fully leveraged into shareholder returns. While the company demonstrates strong operational efficiency with a 35.8% gross margin and accelerating revenue growth of 16.5% year-over-year, its Return on Invested Capital sits at just 5.0%, suggesting capital allocation efficiency lags behind earnings generation potential. The DuPont decomposition reveals that current equity returns are primarily driven by moderate leverage (2.57x) rather than exceptional margin expansion or asset turnover; notably, the low asset turnover of 0.27x indicates significant underutilization of assets relative to sales volume. Despite a solid Piotroski F-Score of 6/9 indicating stable financial health and a negative Beneish M-Score of -2.53 that points away from earnings manipulation risks, the disconnect between high net margins and low ROIC implies management has yet to optimize capital structure or asset intensity to capture full value creation potential.

Valuation metrics suggest the market is pricing in continued growth momentum despite moderate multiple expansion relative to historical norms. Trading at a 19.5x P/E ratio, the stock commands a premium that appears justified by its double-digit revenue acceleration and healthy net margins of 10.9%, though this valuation does not explicitly account for the current inefficiency in ROIC generation. Without specific DCF inputs or sector comparative data provided to establish an absolute fair value range or implied growth trajectory, the market multiple reflects confidence in future margin durability rather than current capital efficiency. Investors must weigh whether the 16.5% revenue expansion can eventually drive higher asset turnover and ROIC to support sustained earnings per share growth at these multiples, or if valuation compression may occur as the gap between profitability and return on invested capital narrows over time.

Risk assessment highlights a notable divergence between insider positioning and public sentiment regarding near-term catalysts. Over the past 90 days, insiders have executed net selling of approximately $159,829, which contrasts with the company's positive fundamental trajectory; this activity could signal management concerns about short-term liquidity needs or valuation levels despite the strong operational backdrop. While the low Beneish M-Score mitigates earnings quality risks and the Piotroski score supports balance sheet stability, the insider outflow serves as a counterweight to the bullish revenue story, suggesting that internal stakeholders may be taking profits ahead of anticipated market re-rating rather than accumulating for further upside.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

6/9
Piotroski F-Score
Average — mixed operational signals
1.1
Altman Z-Score
Distress Zone — below 1.8 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.53
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

35.8%
Gross Margin
10.9%
Net Margin
5.0%
ROIC
7.8%
WACC
ROIC − WACC Spread: -2.8%— Negative spread.
+16.5%
Revenue Growth (YoY)
+18.6%
Earnings Growth (YoY)
-128.4M
Free Cash Flow

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

10.9%
Net Profit Margin
NI ÷ Revenue
×
0.27x
Asset Turnover
Revenue ÷ Assets
×
2.57x
Equity Multiplier
Assets ÷ Equity
=
7.7%
Return on Equity
Balanced ROE composition across margins, turnover, and leverage.

Balance Sheet Health

1.57x
Debt / Equity
0.60x
Current Ratio
3.3x
Interest Coverage
3.0x
Net Debt / EBITDA
-1.67%
FCF Yield
781.5M
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
$-159,829
Net Selling
0
Buy Transactions
2
Sale Transactions
2026-03-06RODRIGUEZ EDUARDO ASold 1/8 qtrsSale$73,389
2026-02-24BRUMFIELD BRIAN FSold 1/8 qtrsSale$86,440
2026-02-13DINAN CURTIS LGrant$616,793
2026-02-13MCCORMICK JOSEPH L. J.D.Grant$327,279
2026-02-13MCANNALLY ROBERT SGrant$2M

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✓ Beat
Est: $1.86
Act: $1.98
+6.6%
Q3
✗ Miss
Est: $0.53
Act: $0.53
-0.6%
Q2
✓ Beat
Est: $0.42
Act: $0.44
+3.8%
Q1
✗ Miss
Est: $1.43
Act: $1.42
-0.4%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

17.2
Forward P/E
PEG Ratio
1.56
Price/Book
466061
Avg Volume
$88.03
52W High
$69.75
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$451M
Tracked Passive Exposure
8
ETFs Holding OGS
0.09%
Avg Weight in ETFs
$506B
Total ETF AUM

When investors buy or sell ETFs like VPU or MDYV, the fund manager is mechanically forced to buy or sell OGS shares regardless of OGS's individual fundamentals. We estimate $451M of passive capital is structurally linked to OGS through 8 tracked ETFs. Passive flows have a limited but growing influence on OGS's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in OGS to visualize passive redemption contagion across ETFs and collateral stocks.

OGS Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
OGSEpicenterVBETFVYMETFVXFETFNEEHigh RiskSOHigh RiskDUKHigh RiskCEGMed RiskAEPHigh Risk
OGS Price Drop (%)0

If OGS (OGS) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies NextEra Energy Inc. (NEE) as the most exposed collateral stock, sharing 1 ETFs with OGS. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 11 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

OGS Ownership Dynamics

Ticker
OGS

Float lock-up computed from 11 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

OGS Capital Efficiency

How efficiently does OGS convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$-128,393,000
EBITDA
$782M
FCF Conversion
-16%
Reinvestment Rate
116%
-16% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
5.0%
ROIC − WACC Spread
-2.8%

OGS converts -16% of its EBITDA into free cash flow, negative FCF conversion — the company is consuming cash faster than it generates EBITDA, which is unsustainable long-term. The 116% reinvestment rate signals aggressive capacity expansion. However, the ROIC-WACC spread is negative (-2.8%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-13921$84.78$78,082.38
2026-05-0645$86.69$3,901.05
2026-04-30340$87.61$29,787.4
2026-04-24773$88.76$68,611.48
2026-03-31146$86.17$12,580.82
2026-03-27722$85.79$61,940.38
2026-03-2327$83.87$2,264.49
2026-03-174,997$86.99$434,689.03
2026-03-109,588$87.15$835,594.2
2026-02-2312$85.52$1,026.24
2026-02-2037$85.55$3,165.35
2026-02-041,985$80.51$159,812.35
2026-01-28916$79.18$72,528.88
2026-01-2085$78.71$6,690.35
2026-01-151$77.55$77.55
2026-01-126$77.01$462.06
2026-01-0812$76.81$921.72
2025-12-122,965$77.05$228,453.25
2025-12-112,607$76.78$200,165.46
2025-11-2617$82.97$1,410.49
2025-11-24102$82.92$8,457.84
2025-11-20201$81.43$16,367.43
2025-11-1329,152$81.77$2.4M
2025-10-281$83.17$83.17
2025-10-206,249$82.08$512,917.92
2025-10-1496$79.64$7,645.44

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare OGS to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.